Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SLC37A1 |
| Upstream (Parents) |
|---|
| (<<) RAB25 → SLC37A1 |
| (<<) CDCP1 → SLC37A1 |
| (<<) S100A11 → SLC37A1 |
| Downstream (Children) |
|---|
| SLC37A1 → TFF1 (>>) |
| SLC37A1 → MUC1 (>>) |
| SLC37A1 → LYPD3 (>>) |
| SLC37A1 → LOC283079 (>>) |
| SLC37A1 → FGF14 (>>) |
| SLC37A1 → SPINK5 (>>) |
| SLC37A1 → TFAP2A (>>) |
| SLC37A1 → NPAS2 (>>) |
| SLC37A1 → TP63 (>>) |
| SLC37A1 → BACE2 (>>) |
| SLC37A1 → FUZ (>>) |
| SLC37A1 → PRSS53 (>>) |
| SLC37A1 → ATP13A2 (>>) |
| SLC37A1 → ZBTB20 (>>) |
| SLC37A1 → OTUB2 (>>) |
